Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw footpad size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / External genitalia morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Snout morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Incubation time
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.603
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Comment
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Kyphosis
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Body weight before experiment
|
HOM
|
f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Lumbar processes
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Incisors morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / 6kHz-evoked ABR Threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.131
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Trunk curl
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 LC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cortical Bone MicroCT / Cortical Bone Mineral Density
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Lens Opacity
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.180
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb skin appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.156
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - cell count
|
HOM
|
f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Vertebral Microradiography / Vertebral Height
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindlimb size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Zygomatic bone
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.667
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i B cell panel
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Shape of ribs
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of CD45
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / 30kHz-evoked ABR Threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0479
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of CD45+ vg5- MHC II- cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Viability Primary Screen / Viability Outcome
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head bobbing/circling
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Corneal vascularization
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retinal Blood Vessels Pattern
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 count of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0224
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Platelet count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.875
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / External genitalia
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Days post activation
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindlimb morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Transfer arousal
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb skin colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Scoliosis
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Incisor colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Comment
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 ratio of vg5+ DETC/LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb and hindlimb grip strength measurement mean
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00419
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Lens
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.180
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i Myeloid panel
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Contact righting reflex
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Comments
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.863
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Persistence of hyaloid vascular system
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1+ f2 + gc cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 CD45+ vg5- MHC II- cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1 + f2 + gc cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Vertebra Compression / Vertebra Yield Load
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Maxilla/Pre-maxilla
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / NK cells - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of CD45+ vg5- MHC II- cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Gait (inc. ataxia)
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail coat/hair appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Caudal processes
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral skin appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal coat/hair colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Body weight
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.644
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Convulsions
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 CD45+ vg5- MHC II- cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw digit size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb grip strength measurement mean
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0231
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Pre-Day 10 Death
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Cornea
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.655
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.735
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / 12kHz-evoked ABR Threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.128
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of B220+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Peyer's Patch
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Iris Pigmentation
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Tissue dissociation method
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel singlets cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 0.3125:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Thoracic processes
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.386
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Humerus
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - % of lymphocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Lordosis
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral skin colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 CD45+ vg5- MHC II- cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Sacral processes
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw digit count
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel live cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Body weight after experiment
|
HOM
|
f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / External genitalia size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Bone Area
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.480
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 tissue volume
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Adrenal Gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail skin colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of B220+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Olfactory lobe
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.718
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Fertility of Homozygous Knock-out Mice / Gross Findings Female
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Skull shape
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forelimb
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Pupil Light Response
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Corneal opacity
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 0.625:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Shape of ribcage
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Collagenase digestion
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B cell panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.494
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Comment
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of thoracic vertebrae
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 ratio of contacting/not contacting vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb coat/hair colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail coat/hair colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail skin appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
0.548
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Killing assay kit
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 1.25:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Prostate gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Vibrissae shape
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.637
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.671
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of B220+
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / KLRG1+ mature NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Ovary
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Aorta
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.742
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forelimb size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail elevation
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Parathyroid gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / Body weight
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of contacting/not contacting vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail coat/hair colour pattern
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of CD45+ vg5- MHC II- cells/vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1+ f2 + gc cells - IMPC panel cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of cervical vertebrae
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Eyelid closure
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head coat/hair colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb coat/hair colour pattern
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.820
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Syndactylism
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 2.5:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forelimb morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Narrow eye opening
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.742
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of B220+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Mammary gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Vibrissae colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Gall Bladder
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw footpad size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Fertility of Homozygous Knock-out Mice / Gross Findings Male
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Lung
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total myeloid cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Skin
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of contacting/not contacting vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cortical Bone MicroCT / Cortical Thickness
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Brown Adipose Tissue
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / Click-evoked ABR threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0907
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Synechia
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.628
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.544
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Pelvis
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t1 + t2 cells - IMPC panel cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Eyelid morphology
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.0182
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Shape of spine
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Femoral Microradiography / Femoral Bone Mineral Content
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Vertebra Compression / Vertebra Max Load
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Type of gd T cell
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-low cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb grip strength measurement
|
HOM
|
24f:21m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - % of cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Positional passivity
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Myeloid cells - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head coat/hair colour pattern
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Digit coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 5:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average branch length of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Mouth morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of digits
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - % of B220+
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Comment
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dysmorphology comment
|
HOM
|
1f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Average histology score
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
0.401
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Incisors
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of contacting/not contacting vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Bone
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.703
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Eye Hemorrhage or Blood Presence
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cortical Bone MicroCT / Internal Diameter
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / 10:1 stdev
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Weight / Body weight
|
HOM
|
75f:76m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Fusion between cornea and lens
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw size
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.552
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Fusion of ribs
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb grasping
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / T cells - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - % of DC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - IMPC panel cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head coat/hair appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 count of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Vertebra Compression / Vertebra Stiffness
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ CD44+ CD62L- alpha beta effector T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Pancreas
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Joints
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb and hindlimb grip strength measurement
|
HOM
|
24f:21m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Red blood cell distribution width
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.839
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 2 score
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of B220+
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Oviduct
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1+ f2 + gc cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Small Intestine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector gd cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Bulging eye
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NKT cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Cartilage tissue
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - % of B220+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Iris/Pupil
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Heart Weight / Heart weight normalised against body weight
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Testis
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Total food intake
|
HOM
|
f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Fibula
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Shape of vertebrae
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Body length
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0214
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % lysis
|
HOM
|
6f:12m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 2 B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Blood vessel
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head skin colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral coat/hair colour pattern
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 tissue volume
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Count of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00174
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Body weight
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.149
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Myeloid panel singlets cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail length
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.715
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Kidney
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.378
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total DC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - % of DC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw nail colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HOM
|
f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Digit coat/hair colour pattern
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD44+ CD62L- alpha beta effector T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Follicular B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / White Adipose Tissue
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 1 B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Stomach
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ KLRG1+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Cerebral Cortex
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Gamma delta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Pupil Position
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of CD45+ vg5- MHC II- cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Plasmacytoid DC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Fusion of vertebrae
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.606
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Tibia
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Striatum
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Head skin appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw footpad skin appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Digit coat/hair appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Count of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 t3 + f1+ f2 + gc cells - % of lymphocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Grip Strength / Forelimb grip strength normalised against body weight
|
HOM
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00367
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0299
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Femoral Microradiography / Femur Length
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Alive
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral coat/hair colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.632
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Corneal touch reflex
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-low cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw nail morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Plasmacytoid DC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Granulocytes + monocytes - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Liver
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / Target cell
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total DC - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Conventional DC (cDC) - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindlimb
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of ribs right
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retina
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.370
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00157
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 marginal zone + precursor cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 count of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD103+ CD11b-low cDC - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw digit fusion
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Comment
|
HOM
|
f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of NK cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tail
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral coat/hair appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Three-point Bend / Energy Dissipated Prior to Fracture
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of total T cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Limb coat/hair appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Total section 1 score
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average no of branches on vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Femur
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Pituitary gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Eosinophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.124
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Follicular B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna position
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Lymph Node
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Red blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.669
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw coat/hair colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw digit count
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw footpad skin colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Startle response
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Eosinophils - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % CD8+
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Brainstem
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Ratio of vg5+ DETC/LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Conventional DC (cDC) - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of CD45+ vg5- MHC II- cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00889
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / CD11b-high cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4- NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of lumbar vertebrae
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Ulna
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD11b-high cDC - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Skeletal muscle tissue
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Buffers and enzymes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Digit coat/hair presence
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of caudal vertebrae
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / NK cell percentage
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of ribs left
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw nail colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Transitional 1 B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retinal Pigmentation
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / IgD+ mature B cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of LC
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Thymus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw digit morphology
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t1 + t2 cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / T cell panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw digit size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average volume of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Transitional 2 B cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Trachea
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Severe Markers
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Cytotoxic T cell function / % CD4+
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Spleen
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Langerhans cell (LC) count
|
HOM
|
2f:2m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Digit coat/hair colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 count of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0171
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.426
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ CD25+ alpha beta regulatory T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Granulocytes - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Lean mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.575
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Number of pelvic vertebrae
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / NK cell - % of CD45+
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Tremor
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / White blood cell count
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.695
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Total B cells - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Ophthalmoscope Observation
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel lymphocyte gate cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0729
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal coat/hair appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ T helper cells - % of CD4+ T helper cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Trabecular Bone MicroCT / Trabecular Thickness (mm)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B1a cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Radius
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean platelet volume
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.316
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average no of branches on vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Brachydactyly
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Hypothalamus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw nail morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Scapulae
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4- NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw digit fusion
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Naive CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Lower Urinary Tract
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Vg5+ dendritic epidermal T cell (DETC) count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retinal Structure
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 vg5+ DETC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / T cell panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retina (combined)
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.266
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Uterus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Heart Weight / Body weight
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Polysyndactylism
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 ratio of vg5+ DETC/LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average roundness of CD45+ vg5- MHC II- cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Hematocrit
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.205
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average volume of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Granulocytes + monocytes - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Clow monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Spinal cord
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Area
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Pupil Dilation
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Three-point Bend / Stiffness
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw coat/hair appearance
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-pro B cells (Hardy fraction A) - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Total water intake
|
HOM
|
f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal skin colour
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 count of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Body Weight
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / 18kHz-evoked ABR Threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.199
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD103+ CD11b-low cDC - % of CD11b-low cDC
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Clavicle
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Weight / Body weight curve
|
HOM
|
99f:105m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Brain
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total Treg cells - % of CD4+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 count of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B cell panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Trabecular Bone MicroCT / Trabecular Spacing (mm)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Mature B cells (Hardy fraction F) - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4- NKT cells - % of CD4- NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC not contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Digit integrity
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ NKT cells - % of NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Marginal zone precursor B cells - % of B2 cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw nail length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Slit Lamp observation
|
HOM
|
1f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.462
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.700
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal coat/hair colour pattern
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average volume of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Three-point Bend / Fracture Load
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Thyroid gland
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD8+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Ly6Chigh monocyte number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - % of CD45+
|
HOM
|
1f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 vg5+ DETC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Epithelium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / CD45+ vg5- MHC II- cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / BM panel CD45+ cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw digit morphology
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average branch length of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.155
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Total T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector gd cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total ab T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 ratio of vg5+ DETC/LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Optic Disc
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fractions B and C) - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Large Intestine
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Heart Weight / Heart weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.172
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Vibrissae size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Peripheral Nervous System
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of CD45+ vg5- MHC II- cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting gd T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal skin appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B2 marginal zone + precursor cells - % of lymphocytes
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Lamina Propria
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Pupil Shape
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
35f:30m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Cervical processes
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
0.539
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD8+ T cells - % of ab T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ NKT cells - % of CD4+ NKT cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw coat/hair colour pattern
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Comment on XRay image
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Three-point Bend / Yield Load
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Germinal centre B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Hindpaw nail count
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Lamina Propria
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Eye
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 LC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.785
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Tissue volume
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average no of branches on vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD8+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ CD4+ T helper cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Germinal centre B cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Auditory Brain Stem Response / 24kHz-evoked ABR Threshold
|
HOM
|
2f:2m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.00711
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Myeloid panel CD45+ live cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Immature B cells (Hardy fraction E) - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 vg5+ DETC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.500
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Transitional vertebrae
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F1 average volume of CD45+ vg5- MHC II- cells
|
HOM
|
2f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Cerebellum
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna rotation
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total ab T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean cell volume
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction C) - % of CD45+
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - cell count
|
HOM
|
f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total myeloid cells - % of CD45+
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average roundness of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 average branch length of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna skin colour
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Effector NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ gd T cells - % of gd T cells
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw nail length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Macrophages - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total CD4+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retinal Blood Vessels
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Trabecular Bone MicroCT / Trabecular Number (mm-1)
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 2 Epithelium
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Naive CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total gd T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / B1a cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Mandibles
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Vibrissae
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna touch reflex
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Ventral coat/hair presence
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
0.416
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Effector Treg cells - % of Treg
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA score
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA score
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / B2 t3 + f1 + f2 + gc cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pro-B cells (Hardy fraction B) - % of CD45+
|
HOM
|
f:2m
|
Supplied as data
|
1.00
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Vertebral Microradiography / Vertebral Bone Mineral Content
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000803
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Anti-nuclear antibody assay / ANA classification
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Heart
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Area
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Teeth
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average no of branches on vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Paw coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / CD4+ T helper cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / CD4+ alpha beta T cell number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Total NKT cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 LC count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.838
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total CD4+ T cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total Treg cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / KLRG1+ NK cells - % of CD45+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Bone marrow immunophenotyping / Pre-B cells (Hardy fraction D) - cell count
|
HOM
|
1f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.327
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HOM
|
f:66m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / Average roundness of CD45+ vg5- MHC II- cells
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / 3i T cell panel
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.263
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Hippocampus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Adult LacZ / Oesophagus
|
HET
|
1f:1m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting NK cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F2 tissue volume
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Resting CD4+ NKT cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Forepaw nail count
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Whole blood peripheral blood leukocyte immunophenotyping / Neutrophil number
|
HOM
|
7f:7m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average branch length of vg5+ DETC contacting LC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Eye Morphology / Retinal Blood Vessels Structure
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Resting CD8+ T cells - % of CD8+
|
HOM
|
3f:3m
|
Supplied as data
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Macrophages - % of myeloid cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Eosinophils - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / Marginal zone B cells - % of B2 cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Pinna skin appearance
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
X-ray / Fusion of processes
|
HOM
|
7f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Snout size
|
HOM
|
8f:7m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
DSS Histology / Section 1 Severe Markers
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Three-point Bend / Max Load
|
HOM
|
2f:m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Mesenteric Lymph Node Immunophenotyping / KLRG1+ CD8+ T cells - cell count
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Spleen Immunophenotyping / Total B2 cells - % of B cells
|
HOM
|
3f:3m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Ear epidermis immunophenotyping / F3 average roundness of vg5+ DETC
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Combined SHIRPA and Dysmorphology / Dorsal coat/hair length
|
HOM
|
8f:7m
|
|
|
NotProcessed |
Alox12etm1b(EUCOMM)Wtsi
|
WTSI
|
Trabecular Bone MicroCT / Bone Volume/Tissue Volume (%)
|
HOM
|
2f:m
|
|
|
NotProcessed |